Platinum

About: Platinum is a research topic. Over the lifetime, 49675 publications have been published within this topic receiving 1150035 citations. The topic is also known as: Pt & element 78.

Nitrogen doped graphene nanoplatelets as catalyst support for oxygen reduction reaction in proton exchange membrane fuel cell

Abstract: Graphene nanoplatelets have been synthesized by thermal exfoliation of graphitic oxide and nitrogen doped graphene nanoplatelets have been obtained by nitrogen plasma treatment. Graphene nanoplatelets and nitrogen doped graphene nanoplatelets have been used as a catalyst support for platinum nanoparticles for oxygen reduction reactions in proton exchange membrane fuel cells. Platinum nanoparticles were dispersed over these support materials using the conventional chemical reduction technique. The morphology and structure of the graphene based powder samples were studied using X-ray diffraction, Raman spectroscopy, transmission electron microscopy and X-ray photoelectron spectroscopy. A full cell was constructed with platinum loaded nitrogen doped graphene nanoplatelets and the results have been compared with platinum loaded graphene nanoplatelets. A maximum power density of 440 and 390 mW cm−2 has been obtained with platinum loaded nitrogen doped graphene and platinum loaded graphene nanoplatelets as ORR catalysts respectively. Nitrogen plasma treatment created pyrrolic nitrogen defects, which act as good anchoring sites for the deposition of platinum nanoparticles. The improved performance of fuel cells with N-G as catalyst supports can be attributed to the increased electrical conductivity and improved carbon–catalyst binding.

Platinum-based drugs: past, present and future.

Abstract: Platinum-based drugs cisplatin, carboplatin and oxaliplatin are widely used in the therapy of human neoplasms. Their clinical success is, however, limited due to severe side effects and intrinsic or acquired resistance to the treatment. Much effort has been put into the development of new platinum anticancer complexes, but none of them has reached worldwide clinical application so far. Nedaplatin, lobaplatin and heptaplatin received only regional approval. Some new platinum complexes and platinum drug formulations are undergoing clinical trials. Here, we review the main classes of new platinum drug candidates, such as sterically hindered complexes, monofunctional platinum drugs, complexes with biologically active ligands, trans-configured and polynuclear platinum complexes, platinum(IV) prodrugs and platinum-based drug delivery systems. For each class of compounds, a detailed overview of the mechanism of action is given, the cytotoxicity is compared to that of the clinically used platinum drugs, and the clinical perspectives are discussed. A critical analysis of lessons to be learned is presented. Finally, a general outlook regarding future directions in the field of new platinum drugs is given.

Kinetic Model of Platinum Dissolution in PEMFCs

Abstract: This paper presents a mathematical model of oxidation and dissolution of supported platinum catalysts in polymer electrolyte membrane fuel cells (PEMFCs). Kinetic expressions for the oxidation and dissolution reactions are developed and compared to available experimental data. The model is used to investigate the influences of electrode potential and particle size on catalyst stability. © 2003 The Electrochemical Society. All rights reserved.